-
A novel pathogenic frameshift variant in AXIN2 in a man with polyposis and hypodontia
Broekema, M. F., Redeker, E. J. W., Uiterwaal, M. T. & van Hest, L. P., 1 Dec 2023, In: Hereditary Cancer in Clinical Practice. 21, 1, 16.Research output: Contribution to journal › Article › Academic › peer-review
-
A large family with MSH3-related polyposis
Aelvoet, A. S., Hoekman, D. R., Redeker, B. J. W., Weegenaar, J., Dekker, E., van Noesel, C. J. M. & Duijkers, F. A. M., Jan 2023, In: Familial Cancer. 22, 1, p. 49-54 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer
Spaanderman, I. T., Peters, F. S., Jongejan, A., Redeker, E. J. W., Punt, C. J. A. & Bins, A. D., 1 Jun 2021, In: PLOS ONE. 16, 6 June 2021, e0251630.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
